Sven C D van IJzendoorn (Sven C D van Ijzendoorn)

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Prognostic Factors

Top Venues

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Lavinija Matakovic, Qinghong Li, Sven C D van IJzendoorn
Letter to the Editor: Liver Cell Models for Premature Termination Codon Readthrough Analyses. Hepatology (Baltimore, Md.) 74 (3) (2021)
Sven C D van IJzendoorn, Qinghong Li, Yi-Ling Qiu, Jian-She Wang, Arend W Overeem
Unequal Effects of Myosin 5B Mutations in Liver and Intestine Determine the Clinical Presentation of Low-Gamma-Glutamyltransferase Cholestasis. Hepatology (Baltimore, Md.) 72 (4) (2021)
Changsen Leng, Arend W Overeem, Fernando Cartón-Garcia, Qinghong Li, Karin Klappe, Jeroen Kuipers, Yingying Cui, Inge S Zuhorn, Diego Arango, Sven C D van IJzendoorn
Loss of MYO5B expression deregulates late endosome size which hinders mitotic spindle orientation. PLoS biology 17 (11) (2019)
Herschel S Dhekne, Olena Pylypenko, Arend W Overeem, Malik Zibouche, Rosaria J Ferreira, K Joeri van der Velde, Edmond H H M Rings, Carsten Posovszky, Peter van der Sluijs, Morris A Swertz, Anne Houdusse, Sven C D van IJzendoorn
MYO5B, STX3, and STXBP2 mutations reveal a common disease mechanism that unifies a subset of congenital diarrheal disorders: A mutation update. Human mutation 39 (3) (2018)